학술논문
Inferior Outcomes of EU Versus US Patients Treated with CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association with Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use
Document Type
Article
Author
Bücklein, V.; Rejeski, K.; Blumenberg, V.; Ackermann, J.; Frölich, L.; Schmidt, C.; Von Bergwelt, M.; Subklewe, M.; Perez, A.; Wood, A.; Albanyan, O.; Locke, F.; Jain, M.D.; Iacoboni, G.; Barba, P.; Jurinovic, V.; Hoster, E.; Holtick, U.; Gödel, P.; Penack, O.; Bullinger, L.; Kharboutli, S.; Mackensen, A.; Johnson, G.; Patel, K.; Arciola, B.; Mhaskar, R.
Source
In: HemaSphere . (HemaSphere, 11 August 2023, 7(8):E907)
Subject
Language
English
ISSN
25729241